AMGEN INC.

• AMGEN, INC. $21,460,000 In-house, the client's own filings · 7 filings
• TODD STRATEGY GROUP $560,000 Outside firm · 7 filings
• CAPITOL TAX PARTNERS, LLP $420,000 Outside firm · 7 filings
• MILLER STRATEGIES, LLC $420,000 Outside firm · 7 filings
• TARPLIN, DOWNS & YOUNG, LLC $420,000 Outside firm · 7 filings
• THE MCMANUS GROUP $420,000 Outside firm · 7 filings
• THE NICKLES GROUP, LLC $420,000 Outside firm · 7 filings
• TIBER CREEK GROUP $420,000 Outside firm · 7 filings
• WILLIAMS AND JENSEN, PLLC $420,000 Outside firm · 7 filings
• CAPITOL 6 ADVISORS $360,000 Outside firm · 7 filings
• ALPINE GROUP PARTNERS, LLC. $350,000 Outside firm · 7 filings
• BGR GOVERNMENT AFFAIRS $350,000 Outside firm · 7 filings
• CAPITOL COUNSEL LLC $350,000 Outside firm · 7 filings
• EMPIRE CONSULTING GROUP $350,000 Outside firm · 7 filings
• HILLNORTH LLC $252,500 Outside firm · 7 filings
• TIBER CREEK HEALTH STRATEGIES, INC. $200,000 Outside firm · 5 filings
• MR. DAN CRIPPEN $136,000 Outside firm · 4 filings
• AVENUE SOLUTIONS $100,000 Outside firm · 3 filings
• SIGHTLINE ADVOCACY, LLC $80,000 Outside firm · 5 filings
• WASHINGTON ADVOCACY GROUP $75,000 Outside firm · 6 filings
• PANNONE LOPES DEVEREAUX & O'GARA LLC $54,000 Outside firm · 6 filings
• JEFFREY J. KIMBELL & ASSOCIATES, INC. $52,500 Outside firm · 7 filings
• BRAVO STRATEGY GROUP $30,000 Outside firm · 2 filings
• MICHAEL J. LAMOUREUX $10,000 Outside firm · 3 filings
• FEDERAL HEALTH COUNSEL, LLC $0 Outside firm · 7 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

• H.R. 1
  One Big Beautiful Bill Act
  20 filings
• H.R. 1492
  To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…
  10 filings
• H.R. 5526
  Biosimilar Red Tape Elimination Act
  10 filings
• H.R. 1672
  Maintaining Investments in New Innovation Act
  8 filings
• H.R. 3517
  Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
  7 filings
• S. 1040
  A bill to amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Vete…
  7 filings
• H. Con. Res. 14
  Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth…
  7 filings
• S. 1041
  Affordable Prescriptions for Patients Act
  7 filings
• H.R. 3160
  PREVAIL Act
  6 filings
• H.R. 4299
  Protecting Patient Access to Cancer and Complex Therapies Act
  6 filings
• H.R. 946
  ORPHAN Cures Act
  6 filings
• S. 1553
  PREVAIL Act
  6 filings
• S. 1954
  Biosimilar Red Tape Elimination Act
  6 filings
• H.R. 1574
  RESTORE Patent Rights Act of 2025
  5 filings
• H.R. 1968
  Full-Year Continuing Appropriations and Extensions Act, 2025
  5 filings
• H.R. 3152
  Patent Eligibility Restoration Act of 2025
  5 filings
• H.R. 5256
  340B ACCESS Act
  5 filings
• S. 1546
  Patent Eligibility Restoration Act of 2025
  5 filings
• S. 2658
  Medication Affordability and Patent Integrity Act
  5 filings
• H.R. 10628
  Biosimilars Access and Affordability Act
  4 filings
• H.R. 2214
  DRUG Act
  4 filings
• H.R. 3269
  ETHIC Act
  4 filings
• H.R. 4317
  PBM Reform Act of 2025
  4 filings
• H.R. 6166
  Lowering Drug Costs for American Families Act
  4 filings
• H.R. 6485
  Skinny Labels, Big Savings Act
  4 filings
• S. 3019
  No Big Blockbuster Bailouts Act
  4 filings
• S. 3345
  PBM Price Transparency and Accountability Act
  4 filings
• H.R. 1990
  American Innovation and R&D Competitiveness Act of 2025
  3 filings
• H.R. 5509
  Safe Step Act
  3 filings
• H.R. 6624
  Biological Intellectual Property Protection Act of 2025
  3 filings

• 2026 $10,818,000 68 filings
• 2025 $16,892,000 85 filings

• Health Issues 92
• Medicare/Medicaid 81
• Taxation/Internal Revenue Code 38
• Copyright/Patent/Trademark 22
• Budget/Appropriations 15
• Pharmacy 10
• Immigration 7
• Labor Issues/Antitrust/Workplace 7
• Tariff (miscellaneous tariff bills) 7
• Trade (domestic/foreign) 7
• Economics/Economic Development 2
• Government Issues 2
• Medical/Disease Research/Clinical Labs 2

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

• SENATE 114
• HOUSE OF REPRESENTATIVES 109
• Health & Human Services, Dept of (HHS) 26
• Centers For Medicare and Medicaid Services (CMS) 21
• Treasury, Dept of 13
• Executive Office of the President (EOP) 7
• Office of Management & Budget (OMB) 6
• Commerce, Dept of (DOC) 1
• State, Dept of (DOS) 1